Point72 Asset Management »

Halozyme Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7M 5.0M 1.15
2025-06-30 $70M 70M 0.99
2024-12-31 $11M 11M 0.96